Saussele S, Richter J, Guilhot J, et al. "Duration of Deep Molecular Response" Has Most Impact on the Success of Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - Results from the EURO-SKI Trial. ASH 59th Annual Meeting & Exhibition, abstract 313.
Advies over sluisplaatsing talquetamab, epcoritamab en tislelizumab
sep 2023 | Lymfoom, Maag-darm-leveroncologie, MM